The new 100,000 sqm facility required an investment of around $75m. It has an annual production capacity of 150 million packs ...

BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...

must have been filed within 12 months of the earliest corresponding filing on the same drug in the US, the European Union or ...

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

Because of the German Pharmaceutical Market Reorganization Act, the prices reimbursed for new drugs on the German market are ...

While the final decision is set for next month, biotech player Neurizon’s (ASX:NUZ) hopes have been lifted with a view ...

Modern pharmaceuticals have revolutionised disease prevention and treatment. But eventually, the chemicals can end up in rivers, oceans and soils.

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

On Tuesday, Novartis AG (NYSE:NVS) reported third-quarter sales of $12.823 billion, up 9% (+10% on constant currency), ...

Police found 13 tonnes of the class A drug hidden behind bananas in a cargo container that sailed from Ecuador.